Literature DB >> 26310940

Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats.

Denise C Cornelius1, Javier Castillo2, Justin Porter2, Lorena M Amaral1, Nathan Campbell1, Adrienne Paige1, Alexia J Thomas1, Ashlyn Harmon1, Mark W Cunningham1, Kedra Wallace2, Florian Herse3, Gerd Wallukat3, Ralf Dechend4, Babbette LaMarca5.   

Abstract

Preeclampsia (PE) is associated with altered immune activation during pregnancy. We have previously shown that adoptive transfer of CD4(+) T cells from the reduced uterine perfusion pressure (RUPP) rat model of PE increases blood pressure, oxidative stress (ROS), and inflammation in normal pregnant recipient rats. The objective of this study was to determine if blockade of communication via the CD40-CD40 ligand (CD40L) interaction between placental ischemia-induced CD4(+) T cells with endogenous normal pregnant (NP) cells would improve pathophysiology that was previously observed in NP recipient rats of RUPP CD4(+) T cells. Splenic CD4(+) T lymphocytes were magnetically separated, incubated with 2.5 μg/ml anti-CD40 ligandCD40L) overnight, and transferred into NP rats on day 12 of gestation (NP+RUPP CD4(+) T+anti-CD40L). On day 19 of gestation, blood pressure (MAP), blood, and tissues were collected. MAP was 99 ± 2 in NP (n = 13), 116 ± 4 in NP+RUPP CD4(+) T cells (n = 7; P < 0.01); MAP only increased to 104 ± 2 in NP+RUPP CD4(+) T cells+CD40L (n = 24) (P < 0.05 vs. NP+RUPP CD4(+) T cells). Mechanisms of hypertension in response to RUPP CD4(+) T cells include endothelin-1 (ET-1), ROS, and angiotensin II type I receptor (AT1-AA) were analyzed. Inhibition of CD40L binding reduced placental ET-1 to 2.3-fold above NP rats and normalized placental ROS from 318.6 ± 89 in NP+RUPP CD4(+) T cells (P < 0.05) to 118.7 ± 24 in NP+RUPP CD4(+) T+anti-CD40L (P < 0.05). AT1-AA was also normalized with inhibition of CD40L. These data suggest that placental ischemia-induced T-cell communication via the CD40L is one important mechanism leading to much of the pathophysiology of PE.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  B cells; T cells; hypertension; preeclampsia

Mesh:

Substances:

Year:  2015        PMID: 26310940      PMCID: PMC4666934          DOI: 10.1152/ajpregu.00273.2015

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  53 in total

Review 1.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

2.  Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.

Authors:  Carl A Hubel; Gerd Wallukat; Myles Wolf; Florian Herse; Augustine Rajakumar; James M Roberts; Nina Markovic; Ravi Thadhani; Friedrich C Luft; Ralf Dechend
Journal:  Hypertension       Date:  2007-01-08       Impact factor: 10.190

3.  Lymphocyte subpopulations in pregnancy complicated by hypertension.

Authors:  Fadia Mahmoud; A Omu; H Abul; S El-Rayes; D Haines
Journal:  J Obstet Gynaecol       Date:  2003-01       Impact factor: 1.246

Review 4.  Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.

Authors:  Florian Herse; Babbette LaMarca
Journal:  Am J Reprod Immunol       Date:  2012-12-28       Impact factor: 3.886

5.  Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes.

Authors:  Babbette LaMarca; Kedra Wallace; Florian Herse; Gerd Wallukat; James N Martin; Abram Weimer; Ralf Dechend
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

Review 6.  CD40 ligand: a neo-inflammatory molecule in vascular diseases.

Authors:  Ghada S Hassan; Yahye Merhi; Walid Mourad
Journal:  Immunobiology       Date:  2011-04-07       Impact factor: 3.144

7.  Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade.

Authors:  Babbette LaMarca; Josh Speed; Lillian Fournier; Sara A Babcock; Hunter Berry; Kathy Cockrell; Joey P Granger
Journal:  Hypertension       Date:  2008-11-03       Impact factor: 10.190

8.  Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

Authors:  Babbette LaMarca; Marc Parrish; Lillian Fournier Ray; Sydney R Murphy; Lyndsay Roberts; Porter Glover; Gerd Wallukat; Katrin Wenzel; Kathy Cockrell; James N Martin; Michael J Ryan; Ralf Dechend
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

9.  Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation.

Authors:  Babbette Lamarca; Joshua Speed; Lillian Fournier Ray; Kathy Cockrell; Gerd Wallukat; Ralf Dechend; Joey Granger
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-11

Review 10.  Molecular mimicry and immune-mediated diseases.

Authors:  M B Oldstone
Journal:  FASEB J       Date:  1998-10       Impact factor: 5.191

View more
  7 in total

Review 1.  Inflammatory mediators: a causal link to hypertension during preeclampsia.

Authors:  Denise C Cornelius; Jesse Cottrell; Lorena M Amaral; Babbette LaMarca
Journal:  Br J Pharmacol       Date:  2018-09-28       Impact factor: 8.739

2.  Splenocyte transfer exacerbates salt-sensitive hypertension in rats.

Authors:  Daniel J Fehrenbach; John Henry Dasinger; Hayley Lund; Jeylan Zemaj; David L Mattson
Journal:  Exp Physiol       Date:  2020-03-17       Impact factor: 2.969

Review 3.  Identifying immune mechanisms mediating the hypertension during preeclampsia.

Authors:  Babbette LaMarca; Denise C Cornelius; Ashlyn C Harmon; Lorena M Amaral; Mark W Cunningham; Jessica L Faulkner; Kedra Wallace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-20       Impact factor: 3.619

4.  Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia.

Authors:  Jessica L Faulkner; Denise C Cornelius; Lorena M Amaral; Ashlyn C Harmon; Mark W Cunningham; Marie M Darby; Tarek Ibrahim; D'Andrea S Thomas; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-16       Impact factor: 3.619

Review 5.  Hypertension: a new treatment for an old disease? Targeting the immune system.

Authors:  Gisele Facholi Bomfim; Stefany Bruno Assis Cau; Alexandre Santos Bruno; Aline Garcia Fedoce; Fernando S Carneiro
Journal:  Br J Pharmacol       Date:  2018-07-31       Impact factor: 8.739

Review 6.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

7.  Investigation of interleukin-2-mediated changes in blood pressure, fetal growth restriction, and innate immune activation in normal pregnant rats and in a preclinical rat model of preeclampsia.

Authors:  Mark W Cunningham; Lorena M Amaral; Nathan E Campbell; Denise C Cornelius; Tarek Ibrahim; Venkata Ramana Vaka; Babbette LaMarca
Journal:  Biol Sex Differ       Date:  2021-01-06       Impact factor: 5.027

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.